Skip to content

Nordson

US · NDSN #983 by market cap Listed 1970
307.22 -9.59 -3.03%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 3 in the most recent period (2026/Q4).
  • Total institutional ownership (as a % of shares) was little changed.

Ownership vs. money flow

Diverging

Institutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
76.08% -0.01pp
Institutions
948 -3
As of
2026/Q4 vs. prior period

Holder types

Mutual Fund62.96%
Individual/Insider5.65%
Hedge Fund3.79%
Public Company3.34%
Government Pension Fund2.01%
Private Company1.75%
Sovereign Wealth Fund1.33%
Family Office/Trust0.35%
Insurance Company0.24%
Other18.59%

Top holders as of 2026-09-30

BlackRock 7.35% · 4.09M sh
Vanguard Capital Management, LLC 6.77% · 3.77M sh
State Street Global Advisors 5.47% · 3.05M sh
Jennifer Savage 5.29% · 2.95M sh
Vanguard Portfolio Management, LLC 4.14% · 2.30M sh
Nord family descendants 3.75% · 2.09M sh
Geode Capital Management, LLC 3.48% · 1.94M sh
Kayne Anderson Rudnick Investment Management, LLC 2.42% · 1.35M sh
Invesco Capital Management LLC 1.97% · 1.10M sh
Eaton Vance Management 1.94% · 1.08M sh
AQR Capital Management 1.41% · 784.36K sh
Norges Bank Investment Management 1.28% · 715.04K sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 22 buys · 28 sells

NameRoleStake
Sundaram Nagarajan Chief Executive Officer 0.13%
James DeVries Former Executive Vice President of Continuous Improvement 0.09%
Victor Richey Independent Chairperson 0.04%
Frank Jaehnert Independent Director 0.04%
Ginger Jones Independent Director 0.01%
Srinivas Subramanian -- 0.01%
John DeFord Independent Director 0.01%
Jennifer A. Parmentier Independent Director 0.01%
Michael Merriman Independent Director 0.01%
Jennifer McDonough General Counsel 0.01%
Stephen Lovass Former Executive Vice President of Medical and Fluid Solutions 0.00%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-10-31 John DeFord Independent Director Other Acquisition +660 $322.67
2026-10-31 Frank Jaehnert Independent Director Other Acquisition +583 $322.67
2026-10-31 Victor Richey Independent Chairperson Other Acquisition +583 $322.67
2026-10-31 Michael Merriman Independent Director Other Acquisition +583 $322.67
2026-10-31 Christopher Mapes Independent Director Other Acquisition +626 $322.67
2026-10-31 Ginger Jones Independent Director Other Acquisition +583 $322.67
2026-10-31 Milton Morris Independent Director Other Acquisition +583 $322.67
2026-10-31 Jennifer A. Parmentier Independent Director Other Acquisition +583 $322.67
2026-10-30 Joseph Kelley Executive VP of Industrial Precision Solutions Leader Sale to Issuer -1,481 $322.67
2026-10-30 Srinivas Subramanian -- Sale to Issuer -593 $322.67
2026-10-13 Milton Morris Independent Director Open Market Disposition -255 $327.20
2026-09-14 Joseph Rutledge Vice President Open Market Disposition -684 $309.38
2026-09-01 Milton Morris Independent Director Open Market Disposition -156 $316.63
2026-08-31 Justin Hall Executive Vice President of Medical & Fluid Solutions Sale to Issuer -118 $314.40
2026-08-26 Jennifer McDonough General Counsel Open Market Disposition -260 $336.00
2026-08-25 Daniel Hopgood Chief Financial Officer Derivative Exercise and Sale -1,329 $209.73–334.29
2026-07-30 John DeFord Independent Director Other Acquisition +84 $297.78
2026-07-30 Christopher Mapes Independent Director Other Acquisition +42 $297.78
2026-07-30 Joseph Rutledge Vice President Sale to Issuer -274 $297.78
2026-06-03 James DeVries Former Executive Vice President of Continuous Improvement Intent to Sell (Form 144) -6,600 $290.00

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:00 · For reference only, not investment advice and not tailored to your situation.

Nordson discussion 0 comments

Add a comment